Antibodies to glycosphingolipid antigens in patients with immune-mediated cochleovestibular disorders

American Journal of Otology

Volumn 18, Issue 2, 1997, Pages 175-178

  Lake III, Gary M ^a   Sismanis, Aristides ^a   Ariga, Toshio ^a   Yamawaki, Masanaga ^a   Gao, Yue ^a   Yu, Robert K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti SGLPG antigen; Immune mediated cochleovestibular disorders

Indexed keywords

ANTIBODY; ANTIGEN; GLYCOSPHINGOLIPID;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSIS; FEMALE; HUMAN; MALE; PERCEPTION DEAFNESS; PRIORITY JOURNAL; VERTIGO; VESTIBULAR DISORDER;

ADULT; AGED; ANTIBODIES; ANTIGENS; CHROMATOGRAPHY, THIN LAYER; COCHLEAR DISEASES; FEMALE; GLYCOSPHINGOLIPIDS; HUMANS; MALE; MIDDLE AGED; VESTIBULAR DISEASES;

EID: 0031004223     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Yu RK, Ariga T, Kohriyama T, et al. Autoimmune mechanisms in peripheral neuropathies. Ann Neurol 1990;27:530-5.
2. Yoshino H, Miyatani N, Saito M, et al. Isolated bovine spinal motor neurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy. J Neurochem 1992;59:1684-91.
3. Kohriyama T, Kusunoki S, Ariga T, et al. Subcellular localization of sulfated glucuronic acid-containing glycolipids reacting with anti-myelin-associated glycoprotein antibody. J Neurochem 1987;48:1516-22.
4. Michaelides E, Sismanis A. Glycolipid antigens in the human cochleovestibular system. Presented at the Annual Meeting of the American Otological Society, Orlando, Florida, May 5, 1996.
5. Kohriyama T, Ariga T, Yu RK. Preparation and characterization of antibodies against a sulfated glucuronic acid-containing glycosphingolipid. J Neurochem 1988;51:869-77.
6. Ariga T, Kohriyama T, Freddo L, et al. Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy. J Biol Chem 1987;262:848-53.
7. Schefler WC. Statistics for health professionals. Reading, MA: Addison-Wesley, 1984:225-31.
8. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
9. Hughes GB, Moscicki R, Barna BP, et al. Laboratory diagnosis of immune inner ear disease. Am J Otol 1994;15:198-202.
10. Moscicki RA, Sam Martin JE, Quintero CH, et al. Serum antibody to inner ear proteins in patients with progressive hearing loss. JAMA 1994;272:611-6.
11. McCabe BF. Autoimmune inner ear disease: results of therapy. Adv Otorhinolaryngol 1991;46:78-81.
12. Veldman JE. The immune system in hearing disorders. Acta Otolaryngol (Stockh) 1988;458:67-75.
13. Ylikoski J, House JW. Demyelinating disease as the assumed cause of hearing loss and vertigo. Arch Otorhinolaryngol 1981; 230:161-70.
14. Maeda Y, Brosnan CF, Miyatani N, et al. Preliminary studies on sensitization of Lewis rats with sulfated glucuronyl paragloboside. Brain Res 1991;541:257-64.
15. Hughes GB, Kinney SE, Hamid MA, et al. Autoimmune vestibular dysfunction: preliminary report. Laryngoscope 1985;95:893-7.